Wearables and other technology to facilitate decentralized trials were supposed to ease patient burden. Elisa Cascade explains why the results depend entirely on design.
- The Synchronization Problem Clinical Research Isn't Watching
- Why Ophthalmology Trials Are Clinical Research's Toughest Tech Test
- Why Trustworthy Clinical Trial Data Starts As Analog, Not Digital
- Why Clinical Trial Coordinators Are Still The Human API
- The Cost And ROI Of Agentic AI In Clinical Trials: What Sponsors And CROs Need To Know
- Designing eCOA Technology Patients Can Actually Use
- Clinical Trial Technology Doesn't Fail – It Fails At The Handoff
- Why Life Science Tech Pilots Fail After The Demo — And How To Avoid It
ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
Position Your DHT Innovation For Success
Explore three factors that significantly influence the success of clinical trials incorporating digital health technology.
-
How eCOA Improves Patient Experience
Explore how to ensure that clinical trials are truly patient-centered, and why it is critical to do so.
-
Redefining Evidence Generation In Modern Clinical Trials
As trials continue to digitize, learn how connected sensors, COAs, PROs, and other forms of data will come together to form the evidence of tomorrow.
-
Growing Pains: The Real Story Behind Gen AI Development In Clinical Trial Ops
As Gen AI develops and reaches advanced stages it introduces risks such as model hallucinations, which can affect trial accuracy and reliability. Explore how to address these challenges.
-
How eTMF Can Improve Global Clinical Trials
Without the right systems, global trial documentation adds risk. Centralized digital workflows improve visibility, audit readiness, and keep teams aligned, compliant, and efficient.
-
The Agentic AI Connectors That Matter In Clinical Development
An inside look at the architecture behind agentic AI in clinical research, including how modular agents, connectors, and MCP frameworks enable scalable, interoperable automation across complex trial ecosystems.
-
Key Changes For Computerized Systems And Electronic Data
Explore several modifications introduced in the updated guidelines by the European Medicines Agency regarding computerized systems and electronic data in clinical trials.
-
Clinical Trials In The Age Of Cost Caps
On February 7, 2025, the NIH introduced a pivotal policy (NOT-OD-25-068), capping indirect cost recovery at 15% for research grants.
-
Fast, Focused Medical Data Review: Use Cases By A Medical Monitor
See how the right data visualization tool can help medical monitors tailor and improve their data review processes and enhance their ability to identify safety signals both quickly and surely.
-
Why Legacy RTSM Systems Create Risk in Biosimilar Trials
Learn how real-time visibility, adaptive supply planning, and proactive risk management can reduce waste and improve study execution.
- Decentralized Trials Promised Less Burden. Did They Deliver?
- Wireless Connectivity Is A Data Integrity Issue, Not IT
- Why Clinical AI Validation Needs Portability Testing Beyond A Single Accuracy Score
- The Synchronization Problem Clinical Research Isn't Watching
- Why Ophthalmology Trials Are Clinical Research's Toughest Tech Test
RECENT NEWSLETTERS
- 08.13.26 -- AI Urgency, Site-Sponsor Gaps, And Data That Saves Lives
- 08.06.26 -- Clinical Trial Tech: AI, Data Quality, And Faster Study Build
- 08.01.26 -- July's Top Clinical Trial Tech Reads
- 07.30.26 -- Clinical Tech Leadership: Site Burden, AI ROI, And Smarter Trial Tech
- 07.23.26 -- AI, Data Costs, And The Real Barriers To Trial Execution